Search research articles
Contact Us
Filters
Showing results (201-210 of 212) with videos related to
Page
of 22
Sort By:
Yi Chuan = Hereditas
|
February 28, 2020
The 2019 novel coronavirus resource
Wen-Ming Zhao, Shu-Hui Song, Mei-Li Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2016
The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical Models
Sen Zhang, Rana Anjum, Rachel Squillace, et al.
Genomics, Proteomics & Bioinformatics
|
March 11, 2021
The Global Landscape of SARS-CoV-2 Genomes, Variants, and Haplotypes in 2019nCoVR
Shuhui Song, Lina Ma, Dong Zou, et al.
Chinese Journal of Integrative Medicine
|
July 5, 2014
Expert consensus for postmarketing Chinese medicine intensive hospital safety monitoring
Xing Liao, Wen Zhang, Yan-Ming Xie, et al.
Genomics, Proteomics & Bioinformatics
|
September 9, 2019
Whole Genome Analyses of Chinese Population and De Novo Assembly of A Northern Han Genome
Zhenglin Du, Liang Ma, Hongzhu Qu, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica
|
January 30, 2014
[Technical specifications for intensive hospital safety monitoring of post-marketing Chinese medicine (draft version for comments)]
Yan-Ming Xie, Xing Liao, Yu-Bin Zhao, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 13, 2011
Discovery of 5-(arenethynyl) hetero-monocyclic derivatives as potent inhibitors of BCR-ABL including the T315I gatekeeper mutant
Mathew Thomas, Wei-Sheng Huang, David Wen, et al.
Journal of Medicinal Chemistry
|
May 5, 2016
Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase
Wei-Sheng Huang, Shuangying Liu, Dong Zou, et al.
Chinese Journal of Integrative Medicine
|
January 11, 2020
Adefovir Dipivoxil plus Chinese Medicine in HBeAg-Positive Chronic Hepatitis B Patients: A Randomized Controlled 48-Week Trial
Xiao-Ke Li, Ming-Xiang Zhang, Feng-Zhen Shao, et al.
Nature Genetics
|
September 5, 2025
A multi-tissue single-cell expression atlas in cattle
Bo Han, Houcheng Li, Weijie Zheng, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 212) with videos related to
Sort By:
Page
of 22
Yi Chuan = Hereditas
|
February 28, 2020
The 2019 novel coronavirus resource
Wen-Ming Zhao, Shu-Hui Song, Mei-Li Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2016
The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical Models
Sen Zhang, Rana Anjum, Rachel Squillace, et al.
Genomics, Proteomics & Bioinformatics
|
March 11, 2021
The Global Landscape of SARS-CoV-2 Genomes, Variants, and Haplotypes in 2019nCoVR
Shuhui Song, Lina Ma, Dong Zou, et al.
Chinese Journal of Integrative Medicine
|
July 5, 2014
Expert consensus for postmarketing Chinese medicine intensive hospital safety monitoring
Xing Liao, Wen Zhang, Yan-Ming Xie, et al.
Genomics, Proteomics & Bioinformatics
|
September 9, 2019
Whole Genome Analyses of Chinese Population and De Novo Assembly of A Northern Han Genome
Zhenglin Du, Liang Ma, Hongzhu Qu, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica
|
January 30, 2014
[Technical specifications for intensive hospital safety monitoring of post-marketing Chinese medicine (draft version for comments)]
Yan-Ming Xie, Xing Liao, Yu-Bin Zhao, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 13, 2011
Discovery of 5-(arenethynyl) hetero-monocyclic derivatives as potent inhibitors of BCR-ABL including the T315I gatekeeper mutant
Mathew Thomas, Wei-Sheng Huang, David Wen, et al.
Journal of Medicinal Chemistry
|
May 5, 2016
Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase
Wei-Sheng Huang, Shuangying Liu, Dong Zou, et al.
Chinese Journal of Integrative Medicine
|
January 11, 2020
Adefovir Dipivoxil plus Chinese Medicine in HBeAg-Positive Chronic Hepatitis B Patients: A Randomized Controlled 48-Week Trial
Xiao-Ke Li, Ming-Xiang Zhang, Feng-Zhen Shao, et al.
Nature Genetics
|
September 5, 2025
A multi-tissue single-cell expression atlas in cattle
Bo Han, Houcheng Li, Weijie Zheng, et al.
Page
of 22